The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC).
 
Payal Deepak Shah
Stock and Other Ownership Interests - Amgen, Johnson & Johnson, Novo Nordisk; Johnson & Johnson, Novartis, Novo-Nordisk, Pfizer, Merck (I)
Consulting or Advisory Role - Novartis
 
Sarat Chandarlapaty
Honoraria - Bayer; Daiichi Sankyo; GlaxoSmithKline; Prometheus; Takeda
Research Funding - Lilly (Inst)
Travel, Accommodations, Expenses - Bayer; GlaxoSmithKline; Takeda
 
Maura N. Dickler
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech/Roche; Merrimack; Novartis; Pfizer; Syndax
Research Funding - Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst)
 
Gary Ulaner
No Relationships to Disclose
 
Stephen James Zamora
No Relationships to Disclose
 
Valentina Sterlin
No Relationships to Disclose
 
Alexia Iasonos
No Relationships to Disclose
 
Christina Marie Coughlin
Employment - Novartis (I)
 
Alex Morozov
Employment - Novartis
 
Joy Ero
Employment - Novartis
 
Neal Rosen
No Relationships to Disclose
 
Teresa Gilewski
No Relationships to Disclose
 
Monica Nancy Fornier
No Relationships to Disclose
 
Nancy T. Sklarin
No Relationships to Disclose
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics
 
Mary Ellen Moynahan
Research Funding - Novartis
 
Clifford A. Hudis
Other Relationship - Breast Cancer Research Foundation
 
Jose Baselga
Consulting or Advisory Role - Novartis
 
Shanu Modi
Research Funding - Genentech; Novartis; Seagen; Synta